Photo of Neil Hays
R Oklahoma House · District 13 On the 2026 ballot

Rep. Neil Hays

Compare
Total votes
4,237
all sessions
Attendance
86%
533 missed
Near the chamber average
With party
90%
of cast votes
Lower than 89% of chamber peers
Bipartisan score
5%
crosses aisle rarely
Higher than 87% of chamber peers
Sponsored
125
bills & resolutions
Higher than 75% of chamber peers
Committees
3
assignments
4,237 roll-call votes

Voting record

Yea
3,291
voted in favor
Nay
413
voted against
Absent
533
missed votes
Total cast
4,237
across all sessions
Crossed party
339
votes against own party
This page
4,237
matching current filters
Bill
Description
Vote
Result
Tally
Date
HB 2816
Sunset; State Anatomical Board; re-creating Board; modifying termination date.
Absent
Passed
83–0
Mar 9, 2023
HB 2559
Teacher scholarships; Oklahoma Future Teacher Scholarship and Employment Incentive Program; renaming program to Inspired to Teach Program; effective date.
Absent
Passed
90–0
Mar 9, 2023
HB 1544
Schools; positions in the school system; adding a definition for athletic trainer; effective date.
Absent
Passed
77–2
Mar 9, 2023
HB 2027
Revenue and taxation; sales tax exemption; hearing aids; effective date; emergency.
Absent
Passed
89–1
Mar 9, 2023
HB 2239
Water preservation; creating the Terry Peach North Canadian Watershed Restoration Act; defining terms; creating certain pilot program; repealer; emergency.
Absent
Passed
86–0
Mar 9, 2023
HB 2811
Sunset; State Board of Licensed Social Workers; re-creating Board; modifying termination date.
Absent
Passed
87–0
Mar 9, 2023
HB 2812
Sunset; State Board of Examiners of Psychologists; re-creating Board; modifying termination date.
Absent
Passed
86–0
Mar 9, 2023
HB 1332
Professions and occupations; Alarm, Locksmith and Fire Sprinkler Industry Committee; modifying powers and duties of the Committee; effective date.
Absent
Passed
77–0
Mar 9, 2023
HB 2818
Sunset; Opioid Overdose Fatality Review Board; re-creating Board; modifying termination date.
Absent
Passed
83–0
Mar 9, 2023
HB 2107
Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.
Absent
Passed
66–31
Mar 9, 2023
Showing 3,971 to 3,980 of 4,237 votes